A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study will be conducted to assess the status of oxidative stress inflammation and
thrombogenesis in patients with hyperlipidemia and to compare the antioxidative,
anti-inflammatory and antithrombogenic effects of rosuvastatin and atorvastatin.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh